• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    11/14/24 1:30:16 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care
    Get the next $WRBY alert in real time by email
    SC 13G/A 1 p24-3222sc13ga.htm WARBY PARKER INC.
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
     
    SCHEDULE 13G/A
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 4)*
     

    Warby Parker Inc.

    (Name of Issuer)
     

    Class A Common Stock, $0.0001 par value

    (Title of Class of Securities)
     

    93403J106

    (CUSIP Number)
     

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    x Rule 13d-1(b)
    ¨ Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 7 Pages)

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 93403J10613G/APage 2 of 7 Pages

     

    1

    NAME OF REPORTING PERSON

     

    D1 Capital Partners L.P.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    7,861,364

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    7,861,364

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    7,861,364

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    7.8%

    12

    TYPE OF REPORTING PERSON

    PN, IA

             

     

     

     

    CUSIP No. 93403J10613G/APage 3 of 7 Pages

     

    1

    NAME OF REPORTING PERSON

     

    Daniel Sundheim

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States of America

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    27,200

    6

    SHARED VOTING POWER

    7,861,364

    7

    SOLE DISPOSITIVE POWER

    27,200

    8

    SHARED DISPOSITIVE POWER

    7,861,364

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    7,888,564

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    7.8%

    12

    TYPE OF REPORTING PERSON

    IN, HC

             

     

     

    CUSIP No. 93403J10613G/APage 4 of 7 Pages

     

    Item 1(a). Name of Issuer.
       
      Warby Parker Inc. (the "Issuer")

     

    Item 1(b). Address of Issuer's Principal Executive Offices.
       
     

    233 Spring Street, 6th Floor East

    New York, New York 10013

     

    Item 2(a). Name of Person Filing.
       
      This statement is filed by D1 Capital Partners L.P. (the "Investment Manager") and Daniel Sundheim (the "Mr. Sundheim").  The foregoing persons are hereinafter sometimes referred to as the "Reporting Persons."
       
      The Investment Manager is a registered investment adviser and serves as the investment manager of private investment vehicles and accounts, including D1 Capital Partners Master LP (the "Investment Vehicle"), and may be deemed to beneficially own the shares of Class A Common Stock held by the Investment Vehicle and/or its subsidiary. Mr. Sundheim indirectly controls the Investment Manager and may be deemed to beneficially own the shares of Class A Common Stock held by the Investment Vehicle and/or its subsidiary.
       
      The filing of this statement should not be construed as an admission that any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, as amended, the beneficial owner of the securities reported herein.

     

    Item 2(b). Address of Principal Business Office.
       
     

    D1 Capital Partners L.P.

    9 West 57th Street, 36th Floor

    New York, New York 10019

       
     

    Daniel Sundheim

    c/o D1 Capital Partners L.P.

    9 West 57th Street, 36th Floor

    New York, New York 10019

     

    Item 2(c). Place of Organization.
       
     

    Investment Manager – Delaware

    Mr. Sundheim – United States of America

     

    Item 2(d). Title of Class of Securities.
       
      Class A common stock, $0.0001 par value (the "Class A Common Stock")

     

    Item 2(e). CUSIP Number.
       
      93403J106

     

    CUSIP No. 93403J10613G/APage 5 of 7 Pages

     

    Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a:

     

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) x An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
      (f) ¨

    An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

      (g) x

    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

     

      (h) ¨

    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);

     

      (i) ¨

    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     

      (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     

      If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: ______________________________________________________

     

    Item 4. Ownership.
       
      The information required by Items 4(a) – (c)  is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.  
       
      The percentages set forth herein are calculated based upon 100,657,415 shares of Class A Common Stock outstanding as of August 6, 2024 as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, filed with the Securities and Exchange Commission on August 8, 2024.

     

    Item 5. Ownership of Five Percent or Less of a Class.
       
      Not applicable.

     

    CUSIP No. 93403J10613G/APage 6 of 7 Pages

     

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
       
      The Investment Vehicle (and/or its subsidiary) has the right to receive and the power to direct the receipt of dividends from, and the proceeds from the sale of, the shares of Class A Common Stock reported herein.  

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
       
      Not applicable.

     

    Item 8. Identification and Classification of Members of the Group.
       
      Not applicable.

     

    Item 9. Notice of Dissolution of Group.
       
      Not applicable.

     

    Item 10. Certification.
       
      By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

    CUSIP No. 93403J10613G/APage 7 of 7 Pages

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Date: November 14, 2024  
      D1 Capital Partners L.P.
       
      By: /s/ Amanda Hector
      Name: Amanda Hector
      Title: General Counsel and Chief Compliance Officer
       
       
       
       
      /s/ Daniel Sundheim
      DANIEL SUNDHEIM
             

     

     

    Get the next $WRBY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WRBY

    DatePrice TargetRatingAnalyst
    4/30/2025$17.00Sell → Neutral
    Citigroup
    4/17/2025$27.00Hold → Buy
    Loop Capital
    2/28/2025$28.00 → $30.00Outperform
    Telsey Advisory Group
    2/25/2025$26.00Neutral
    ROTH MKM
    2/5/2025$19.00 → $23.00Neutral → Sell
    Citigroup
    1/17/2025$23.00Outperform → In-line
    Evercore ISI
    11/19/2024$22.00 → $26.00Outperform
    Telsey Advisory Group
    11/8/2024$19.00 → $22.00Outperform
    Telsey Advisory Group
    More analyst ratings

    $WRBY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Singer Bradley E bought $965,750 worth of shares (75,000 units at $12.88) (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      8/14/24 4:52:02 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    $WRBY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Moon Youngme E was granted 12,020 shares, increasing direct ownership by 22% to 65,889 units (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      6/12/25 7:05:24 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Director Briggs Teresa was granted 12,020 shares, increasing direct ownership by 31% to 50,879 units (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      6/12/25 7:03:46 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Director Williams Ronald A was granted 17,362 shares, increasing direct ownership by 21% to 100,623 units (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      6/12/25 7:02:14 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    $WRBY
    SEC Filings

    See more
    • SEC Form 144 filed by Warby Parker Inc.

      144 - Warby Parker Inc. (0001504776) (Subject)

      5/22/25 4:29:29 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

      8-K - Warby Parker Inc. (0001504776) (Filer)

      5/20/25 2:24:32 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Warby Parker Inc.

      SCHEDULE 13G/A - Warby Parker Inc. (0001504776) (Subject)

      5/12/25 10:20:43 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care